ALERIAN MLP ETF DECLARES FOURTH QUARTER DISTRIBUTION OF $0.95
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 13 2024
0mins
Source: PRnewswire
Alerian MLP ETF Distribution Announcement: The Alerian MLP ETF declared a fourth quarter 2024 distribution of $0.95, payable on November 18, 2024, to shareholders recorded on November 13, 2024.
Investment Risks and Tax Implications: Investors should be aware of the risks associated with Master Limited Partnerships (MLPs), including tax treatment changes that could affect distributions and overall fund value, as well as the fund's classification as a taxable regular corporation.
Analyst Views on SSNC
Wall Street analysts forecast SSNC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SSNC is 103.29 USD with a low forecast of 92.00 USD and a high forecast of 112.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 84.620
Low
92.00
Averages
103.29
High
112.00
Current: 84.620
Low
92.00
Averages
103.29
High
112.00
About SSNC
SS&C Technologies Holdings, Inc. is a global provider of services and software for the financial services and healthcare industries. Its portfolio of products and software-enabled services allows its financial services clients to automate and integrate front-office functions such as trading and modeling, middle-office functions, such as portfolio management and reporting and back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing. The Company provides its solutions within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. It provides solutions to the healthcare industry, including pharmacy, healthcare administration and health outcomes optimization solutions. Its healthcare solutions include claims adjudication, benefit management, care management and business intelligence services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
